Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Int J Med Inform. 2017 Sep 25;108:1–8. doi: 10.1016/j.ijmedinf.2017.09.013

Table 1.

Selected SEER attributes and their respective descriptors. AJCC: American Joint Committee on Cancer.

Number Attribute Description Type
1 Age Age at time of diagnosis. Discrete
2 Grade Appearance of cancer cells and how fast they may grow. Numeric
3 Radiation Sequence with Surgery Order of surgery and radiation therapy administered for patients who received both. Numeric
4 Number of Primaries Number of malignant tumors other than lung. Discrete
5 T AJCC component describing tumor size. Numeric
6 N AJCC component describing lymph node involvement. Numeric
7 M AJCC component describing tumor dissemination to other organs. Numeric
8 Radiation Indication of whether patient has received radiation. Numeric
9 Stage Stage of tumor - based on T, N, and M. Numeric
10 Primary Site Location of tumor within the lungs. Numeric
11 First Malignant Primary Indicator Based on cancers reported in SEER database for patient. Numeric
12 Sequence Number Order of lung cancer occurrence with respect to other cancers for this patient. Discrete
13 CS Lymphnodes Number of lymph nodes involved. Numeric
14 Histology Recode - Broad Groupings Microscopic composition of cells and/or tissues for specific primary. Used for staging and treatment determination. Numeric
15 RXSumm -- ScopeRegLNSur(2003 +) (Scope of Regional Lymph Node Surgery) -- Procedure of removal, biopsy, or aspiration of regional lymph nodes. Numeric
16 RXSumm -- SurgPrimSite(1998+) (Surgery of Primary Site) -- Procedure to remove or destroy tissue of the primary site. Numeric
17 DerivedSS1977 This item is derived “SEER Summary Stage 1977” from the Collaborative Stage (CS) algorithm, effective with 2004+ diagnosis. Numeric
18 TumorSize Measurement of tumor size. Numeric
19 Survival Time Number of months that patient is alive from date of diagnosis. Discrete